Patents Expiring in February 2037
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm | CEQUA | cyclosporine | SOLUTION;OPHTHALMIC | 210913-001 | Aug 14, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE). | ||||
| Sun Pharm | CEQUA | cyclosporine | SOLUTION;OPHTHALMIC | 210913-001 | Aug 14, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ||||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-001 | Dec 15, 2016 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ||||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-001 | Dec 15, 2016 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ||||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-002 | Dec 15, 2016 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ||||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-002 | Dec 15, 2016 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
